leisure time -WSS

leisure time

author：leisure time 2025-10-01 17:06:47 - browse：21

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： 'CMA Fest' 2023: How to watch, who is performing and more

entertainment

WSS

'CMA Fest' 2023: How to watch, who is performing and more

HIV drugs protect against transmission, even in unprotected sex

How to increase colonoscopy rates? Looks like an AI can help

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Intellia reports positive results for its CRISPR

Judge denies Trump's request for new trial in E. Jean Carroll case

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

The high cost of giving birth even with insurance

Letters to First Opinion on caregivers, digital health, and more

Medicare proposal to cover medical devices draws a mixed reaction

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

State Dept. review finds Biden bears some blame for Afghanistan failures

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

DIEP, the 'gold standard' of breast reconstruction, is under threat

'CMA Fest' 2023: How to watch, who is performing and more

DIEP, the 'gold standard' of breast reconstruction, is under threat

Extensive review finds private equity owners jack up cost of care

focus

Ultragenyx gene therapy for rare liver ailment succeeds in late

Delta passengers in Vegas fall sick while waiting on flight in triple

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Dementia risk linked to living in disadvantaged areas: Study

There’s a way to spot data fakery. All journals should be using it

Telehealth startups are trying to fill the menopause care vacuum

Wikipedia

entertainment

leisure time

explore